1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparative outcomes of donor graft CD34 + selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation
    Journal Article

    Pasquini, M. C.; Devine, S.; Mendizabal, A.; Baden, L. R.; Wingard, J. R.; Lazarus, H. M.; Appelbaum, F. R.; Keever-Taylor, C. A.; Horowitz, M. M.; Carter, S.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: Final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
    Journal Article

    Fizazi, K.; Scher, H. I.; Molina, A.; Logothetis, C. J.; Chi, K. N.; Jones, R. J.; Staffurth, J. N.; North, S.; Vogelzang, N. J.; Saad, F.; more...
    Lancet Oncology (2012)

    Fulltext@MSK | Save
  • Risk of rash with the anti-HER2 dimerization antibody pertuzumab: A meta-analysis
    Journal Article

    Drucker, A. M.; Wu, S.; Dang, C. T.; Lacouture, M. E.
    Breast Cancer Research and Treatment (2012)

    Fulltext@MSK | Save
  • NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
    Journal Article

    Stupp, R.; Wong, E. T.; Kanner, A. A.; Steinberg, D.; Engelhard, H.; Heidecke, V.; Kirson, E. D.; Taillibert, S.; Liebermann, F.; Dbaly, V.; more...
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: Results from the CCG-1961 randomised cohort trial
    Journal Article

    Mattano, L. A.; Devidas, M.; Nachman, J. B.; Sather, H. N.; Hunger, S. P.; Steinherz, P. G.; Gaynon, P. S.; Seibel, N. L.
    Lancet Oncology (2012)

    Fulltext@MSK | Save
  • The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: Results from the Gothenburg Randomized Screening Trial
    Journal Article

    Frånlund, M.; Carlsson, S.; Stranne, J.; Aus, G.; Hugosson, J.
    BJU International (2012)

    Fulltext@MSK | Save
  • Optimal management of malignant pleural effusions (results of CALGB 30102)
    Journal Article

    Demmy, T. L.; Gu, L.; Burkhalter, J. E.; Toloza, E. M.; D'Amico, T. A.; Sutherland, S.; Wang, X.; Archer, L.; Veit, L. J.; Kohman, L.
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: A randomized trial
    Journal Article

    Hovanessian-Larsen, L.; Taylor, D.; Hawes, D.; Spicer, D. V.; Press, M. F.; Wu, A. H.; Pike, M. C.; Pearce, C. L.
    Contraception (2012)

    Fulltext@MSK | Save
  • Dabrafenib in BRAF-mutated metastatic melanoma: A multicentre, open-label, phase 3 randomised controlled trial
    Journal Article

    Hauschild, A.; Grob, J. J.; Demidov, L. V.; Jouary, T.; Gutzmer, R.; Millward, M.; Rutkowski, P.; Blank, C. U.; Miller, W. H. Jr; Kaempgen, E.; more...
    Lancet (2012)

    Fulltext@MSK | Save
  • Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401
    Journal Article

    Kelly, W. K.; Halabi, S.; Carducci, M.; George, D.; Mahoney, J. F.; Stadler, W. M.; Morris, M.; Kantoff, P.; Monk, J. P.; Kaplan, E.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save